2025-10-03 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the data provided.

## Procter & Gamble (PG) Stock Analysis

**Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 34.18%
*   **VOO Cumulative Return:** 97.56%
*   **Absolute Divergence:** -63.38%
*   **Divergence Range:** Max: 24.9, Min: -65.1
*   **Relative Divergence:** 1.9

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period. The relative divergence suggests PG's underperformance is near the bottom end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%   | 0.0   | 215.0  |
| 2016-2018  | 9.0%    | 67.3%   | -6.0%   | 0.1   | 215.1  |
| 2017-2019  | 24.0%   | 70.4%   | 2.0%    | 0.3   | 292.3  |
| 2018-2020  | 27.0%   | 78.8%   | 4.0%    | 0.4   | 325.6  |
| 2019-2021  | 41.0%   | 78.8%   | -5.0%   | 0.5   | 382.8  |
| 2020-2022  | 13.0%   | 79.4%   | 13.0%   | 0.6   | 354.7  |
| 2021-2023  | 26.0%   | 79.4%   | 24.0%   | 0.4   | 343.0  |
| 2022-2024  | 9.0%    | 79.4%   | -12.0%  | 0.4   | 392.4  |
| 2023-2025  | -10.0%  | 80.1%   | -72.0%  | 0.2   | 360.2  |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly over different periods, ranging from -10.0% to 41.0%. The most recent period (2023-2025) shows negative growth.
*   **MDD (Maximum Drawdown):** Relatively high MDD across all periods, indicating significant potential losses from peak to trough.
*   **Alpha:** Alpha fluctuates considerably, ranging from -72.0% to 24.0%, indicating varying degrees of outperformance or underperformance relative to the benchmark.  The recent period shows substantial underperformance.
*   **Beta:** Beta values are generally low (0.0 to 0.6), suggesting PG's price is less sensitive to market movements.
*   **Cap(B):** Market capitalization shows growth over the years.

### 2. Recent Stock Price Movements

*   **Current Price:** 153.92
*   **Last Market Data:**
    *   Price: 152.05
    *   Previous Close: 153.18
    *   Change: -0.74
*   **5-Day Moving Average:** 152.6871
*   **20-Day Moving Average:** 156.6141
*   **60-Day Moving Average:** 155.9765

**Analysis:** The stock price is below both the 20-day and 60-day moving averages, suggesting a short-term downtrend. The price decrease in the last market data, change: -0.74, supports the downtrend.

### 3. Market Risk Indicators & Signals

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 35.14 (Approaching Oversold)
*   **PPO (Percentage Price Oscillator):** -0.3838
*   **Hybrid Signal:** Buy 100% of cash (7 shares - Very Safe - MRI:0.90). Monthly invest 0.8% of total investment ($1,000.00).
*   **Delta_Previous_Relative_Divergence:** 1.9 (+): 단기상승
*   **Expected Return (%):** 164.6 (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a generally favorable investment environment for PG.
*   The RSI indicates the stock is approaching oversold conditions, which might signal a potential buying opportunity.
*   PPO indicates bearishness
*   The hybrid signal recommends buying and investing.
*   Delta indicates short term up trend.
*   The high expected return suggests significant long-term outperformance potential compared to the S&P 500 if dollar-cost averaging is followed.
*   The recent market data shows a small price decrease, which could indicate a minor negative catalyst or general market volatility.

### 4. Recent News & Significant Events

*   **Analyst Report: Regeneron Phars, Inc (Argus Research):** This may indirectly affect PG if it influences overall market sentiment or sector-specific trends.
*   **Europe Household Care Market Outlook and Growth Analysis Report 2025-2034:** Positive outlook for the household care market in Europe, where PG has a significant presence.
*   **Restructuring and Brand Cuts Could Be a Game Changer for Procter & Gamble (PG):** Potential for improved efficiency and profitability through strategic restructuring.
*   **Procter & Gamble cuts operations in another country, report says:** Restructuring efforts continue, potentially impacting short-term earnings.
*   **Procter & Gamble (PG) To Announce FQ1 2026 Results on October 24:** Upcoming earnings announcement will be a key event for investors.
*   **Procter & Gamble (PG): A Dividend King with Over Six Decades of Increases:** Highlights the company's strong dividend track record, attractive to income investors.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.04)
*   **Opinions:** 22
*   **Target Price (avg/high/low):** 170.18 / 186.00 / 147.00
*   **Recent Rating Changes:** No changes noted.

**Analysis:** The analyst consensus is "Buy," with an average target price of $170.18, suggesting potential upside.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-24 | 1.58 | 19.78 B$   |
| 2025-01-22 | 1.94 | 21.88 B$   |
| 2024-10-18 | 1.65 | 21.74 B$   |
| 2024-04-19 | 1.56 | 20.20 B$   |
| 2025-04-24 | 1.56 | 20.20 B$   |

**Analysis:** Earnings per share (EPS) and revenue show fluctuations across the quarters.

### 6. Financial Information

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |
| 2024-06-30   | $20.53B    | 49.60%        |

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-06-30   | $52.01B    | 6.95%  |
| 2025-03-31   | $52.27B    | 7.21%  |
| 2024-12-31   | $51.17B    | 9.05%  |
| 2024-09-30   | $51.84B    | 7.64%  |
| 2024-06-30   | $50.29B    | 6.24%  |

**Analysis:**

*   **Revenue:** Revenue has fluctuated over the past year.
*   **Profit Margin:** Profit margins are consistently high, indicating strong pricing power and operational efficiency.
*   **Equity:** Equity has remained relatively stable.
*   **ROE (Return on Equity):** ROE has varied, reflecting the fluctuations in profitability.

### 7. Overall Summary

Procter & Gamble (PG) has underperformed the S&P 500, but analyst consensus is "Buy" with a potential upside. The stock is approaching oversold conditions, potentially indicating a good time to buy. Company fundamentals are strong, with high profit margins, but restructuring efforts and market volatility are affecting the stock.

**Investment Recommendation:**

*   Averaging the stock might be a good investment strategy.
*   Monitor upcoming earnings announcement and any news related to the restructuring initiatives.
*   Given the mixed signals, a cautious and diversified investment approach is advisable.
